Leaders from New and Established Centers to Share Clinical Advances and Proven Operational Strategies to Broaden Patient Access
JACKSONVILLE, Fla., March 3, 2026 — The National Association for Proton Therapy (NAPT), the nation’s leading organization dedicated to increasing patient access to advanced cancer treatments, will convene the 2026 National Proton Conference (NPC) in Nashville on March 18-21. The annual conference follows recent new results from trials showing the survival benefits of proton therapy in treating several types of cancer.
The three-day conference will focus on emerging clinical research, patient quality of life, operational efficiencies, payer relations, increasing patient access, and other issues critical to expanding the nationwide use of this life-saving cancer treatment.
In addition to a lineup of the top proton therapy experts and physicians in the country, Grammy-winning recording artist Amy Grant will accept an award on behalf of her late father, Dr. Burton Grant, a pioneer of radiation oncology in Tennessee. Olympic Gold Medalist Scott Hamilton, a cancer survivor treated with proton therapy, will be on hand to deliver the conference’s closing remarks.
“With proton therapy continuing to expand across the country and new centers broadening patient access, there has never been a more important time to bring together the leaders, clinicians, researchers, and advocates advancing this field,” said NAPT Executive Director Jennifer Maggiore. “The 2026 National Proton Conference will focus on improving access to care and working collaboratively to ensure this treatment is available to those who need it most.”
NPC 2026 attendees include physicians, physicists, proton therapy operational leaders, dosimetrists, radiation therapists and nurses, patient advocates, corporate partners, and more.
More than 70 speakers from cancer centers across the country will share their insights. The final day of programming will include a special session of PTCOG-NA, a Dosimetry Workshop, and tour of the host center, Tennessee Oncology Proton Center. In addition, the NPC exhibition hall will feature industry partners and technology providers. Industry Expert Theaters will be presented by Mevion, IBA, and Apollo Healthcare Partners.
For more information, a full list of speakers, or to register for the conference, please visit www.nationalprotonconference.com.
About The National Association for Proton Therapy
The National Association for Proton Therapy (NAPT) is an independent nonprofit organization founded in 1990 to educate and increase awareness about the clinical benefits of proton therapy. Its members include 52 of the nation’s leading cancer centers, many of which are National Cancer Institute (NCI)-designated comprehensive cancer centers and National Comprehensive Cancer Network (NCCN) members. The mission of NAPT is to work collaboratively to raise public awareness of the clinical benefits of proton therapy, ensure patient choice and access to affordable proton therapy, and encourage cooperative research and innovation to advance the appropriate and cost-effective utilization of proton therapy.
